These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1771720)

  • 21. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor response and treatment complications in radiotherapy of localized prostate cancer.
    Strnad V; Tacev T; Prokes B; Ott O; Krystof V; Svobodova M; Rasovska O; Konecny M
    Strahlenther Onkol; 1990 Nov; 166(11):728-32. PubMed ID: 2124375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [External radiotherapy with curative intent for adenocarcinoma clinically localized to the prostate (T1 to T3N0M0): intermediate results with a minimum follow-up of 4 years].
    Rohner S; Bieri S; Graber P
    Ann Urol (Paris); 1994; 28(4):221-8. PubMed ID: 7979212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma.
    Copeland LA; Elshaikh MA; Jackson J; Penner LA; Underwood W
    Cancer; 2005 Oct; 104(7):1372-80. PubMed ID: 16118801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
    Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of radiation therapy in the treatment of cancer of the prostate.
    Korzeniowski S
    Neoplasma; 1988; 35(4):443-57. PubMed ID: 3054590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months.
    Ogawa K; Nakamura K; Sasaki T; Onishi H; Koizumi M; Shioyama Y; Araya M; Mukumoto N; Mitsumori M; Teshima T;
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):759-65. PubMed ID: 19327908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer: results of external irradiation.
    Reddy EK; Krishnan L; Giri S; Evans RG; Mebust WK; Weigel JW
    J Natl Med Assoc; 1993 Feb; 85(2):109-12. PubMed ID: 8441185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interstitial brachytherapy--a minimal invasive urological option for treatment of prostate cancer of increasing importance].
    Slany E; Senger V; Maurer U; Zumbè J
    Versicherungsmedizin; 2004 Dec; 56(4):187-92. PubMed ID: 15633772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-metastasized prostate cancer with spread outside the capsule treated with megavolt radiation].
    van der Werf-Messing B
    Ned Tijdschr Geneeskd; 1979 May; 123(19):778-83. PubMed ID: 108603
    [No Abstract]   [Full Text] [Related]  

  • 33. [Recommendations for permanent, interstitial brachytherapy alone in localized prostate carcinoma].
    Wirth MP; Herrmann T; Alken P; Kovacs G; Müller H; Hakenberg OW; Ahlemann L; Schalkhäuser K
    Urologe A; 2002 Jul; 41(4):369-73. PubMed ID: 12214457
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences with radiation treatment of prostatic cancer].
    Hertel E; Czempiel H; Forster D; Konetzke C; Mauermayer W; Voeth C
    Helv Chir Acta; 1976 Jul; 43(3):333-5. PubMed ID: 820676
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of megavoltage radiation therapy in the treatment of prostatic carcinoma.
    Pistenma DA; Ray GR; Bagshaw MA
    Semin Oncol; 1976 Jun; 3(2):115-22. PubMed ID: 819994
    [No Abstract]   [Full Text] [Related]  

  • 36. Radical radiotherapy in the management of carcinoma of the prostate.
    Jones DA; Eckert H; Smith PJ
    Br J Urol; 1982 Dec; 54(6):732-5. PubMed ID: 6817843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High-voltage curative treatment of stage III prostatic cancer].
    Schønsted-Madsen U
    Ugeskr Laeger; 1979 Feb; 141(6):372-4. PubMed ID: 105437
    [No Abstract]   [Full Text] [Related]  

  • 38. [Follow-up of prostatic cancer after curative radiotherapy].
    Kelly LU; Schorcht J; Strietzel M
    Radiobiol Radiother (Berl); 1979 Feb; 20(1):5-12. PubMed ID: 461732
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostatic cancer revisited.
    Cosgrove MD; Kaempf MJ
    J Urol; 1976 Jan; 115(1):79-81. PubMed ID: 813018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy for t3 prostate cancer.
    Bayley A; Gospodarowicz MK
    Curr Urol Rep; 2003 Jun; 4(3):205-10. PubMed ID: 12756083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.